Inflammatory bowel disease and latent thrombocythemia: A novel cause of hepatic vein thrombosis;Maladie inflammatoire cryptogénétique de l'intestin et thrombocytémie latente: Nouvelle étiologie de thrombose des veines hépatiques?

Gastroenterologie Clinique et Biologique

Volumn 28, Issue 4, 2004, Pages 394-397

  Decaens, Thomas ^a   Maitre, Sophie ^a   Marfaing, Anne ^a   Naveau, Sylvie ^a   Chaput, Jean Claude ^a   Mathurin, Philippe ^a,b  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; HEPARIN;

ADULT; ARTICLE; BONE MARROW CULTURE; CASE REPORT; COLONY FORMATION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; ENTERITIS; FEMALE; FRANCE; HUMAN; LIVER VEIN THROMBOSIS; MEDICAL LITERATURE; MEGAKARYOCYTE; STEM CELL; THROMBOCYTHEMIA; TREATMENT OUTCOME;

EID: 2542482526     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0399-8320(04)94941-x     Document Type: Article

References (24)

1. Lichtiger S, Present DH, Kornbluth A, Gelernt I, Bauer J, Galler G, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994;330:1841-5.
2. Brynskov J, Freund L, Rasmusson SN, Lauritsen K, de Muckadell OS, Willims N, et al. A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease. N Engl J Med 1989;321:845-50.
3. Kirsner JB. The local and systemic complications of IBD. JAMA 1979;242:1177-83.
4. Talbot RW, Heppell J, Dozois RR, Beart RW. Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1986;61:140-5.
5. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton III LJ. Trends in the incidence of deep vein thrombosis and pulmonary embolism. A 25-year population based study. Arch Intern Med 1998;158:585-93.
6. Kelsey MP, Comfort MW. Occlusion of the hepatic veins: a review of twenty cases. Arch intern med 1945;75:175-83.
7. Jorgensen L. Occlusion of the hepatic veins: report of two cases. Acta Pathol Scand 1958;44:68-79.
8. Chesner IM, Muller S, Newman J. Ulcerative colitis complicated by Budd-Chiari syndrome. Gut 1986;27:1096-100.
9. Brinson RR, Curtis D, Schuman BM, Millis LR. Recovery from hepatic vein thrombosis (Budd-Chiari syndrome) complicating ulcerative colitis. Dig Dis Sci 1988;33:1615-20.
10. Kraut J, Berman JH, Gunasekaran TS, Allen R, McFadden J, Messersmith R, et al. Hepatic vein thrombosis (Budd-Chiari syndrome) in a adolescent with ulcerative colitis. J Pediatr Gastroenterol Nutr 1997;25: 417-20.
11. Whitefort MH, Moritz MJ, Feber A, Frey RD. Budd-Chiari syndrome complicating restorative proctocolectomy for ulcerative colitis. Dis Colon Rectum 1999;42:1220-4.
12. Denninger MH, Chaït Y, Casadevall N, Hillaire S, Guillin MC, Bezeaud A, et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 2000;31:587-91.
13. Shafer AI. Hypercoagulable states: molecular genetics to clinical practice. Lancet 1994;344:1739-42.
14. Buckell NA, Williams GT, Bartram CI, Lennard-Jones JE. Depth of ulceration in acute colitis. Correlation with outcome and clinical and radiologic features. Gastroenterology 1980;79:19-25.
15. Michiels JJ, Juvonen E. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group. Semin Thromb Hemost 1997;23:339-47.
16. Rolovic Z, Basara N, Gotic M, Sefer D, Bogdanovic A. The determination of spontaneous megakaryocyte colony formation is an unequivocal test for discrimination between essential thrombocythaemia and reactive thrombocytosis. Br J Haematol 1995;90:326-31.
17. Mitchell MC, Boinott JK, Kaufman S, Cameron JL, Maddrey WC. Budd-Chiari syndrome: etiology, diagnosis and management. Medecine 1982;61:199-218.
18. Lee LC, Spittell JA Jnr, Saver WG, Owen CA Jnr, Thomson JH. Hypercoagulability associated with chronic ulcerative colitis - changes in blood coagulation factors. Gastroenterology 1968;54:76-85.
19. Lake AM, Stauffer JQ, Stuart MJ. Haemostatic alteration in inflammatory bowel disease. Response to therapy. Am J Dig 1978;23:897-902.
20. Zeitoun G, Escolano S, Hadengue A, Azar N, El Younsi M, Mallet A, et al. Outcome of Budd-Chiari Syndrome: a multivariate analysis of factros related to survival including surgical portosystemic shunting. Hepatology 1999;30:84-9.
21. Min AD, Atillasoy EP, Schwartz ME, Thiim M, Miller CM, Bodenheimer HC Jr. Reassessing the role of medical therapy in the management of hepatic vein thrombosis. Liver Transplant Surg 1997;3:423-9.
22. De Stefano V, Teofili L, Leone G, Michiels JJ. Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Budd-Chiari syndrome or portal vein thrombosis. Semin Thromb Hemost 1997;23:339-47.
23. nd ed. Paris: 2002: 1004-11.
24. Valla D, Casadevall N, Lacombe C, Varet B, Goldwasser E, Franco D, et al. Primary myeloproliferative disorder and hepatic vein thrombosis. Ann Intern Med 1985;103:329-34.